Sanofi buys US biopharma group Blueprint in $9.1 billion deal

Technology & Startups

Sanofi buys US biopharma group Blueprint in $9.1 billion deal

June 2, 2025

PARIS (Reuters) -French pharma group Sanofi has agreed to buy US-based Blueprint Medicines Corporation, a biopharmaceutical company specializing in systemic ...

Tag: Paul Hudson

Sanofi buys US biopharma group Blueprint in $9.1 billion deal

Family calls for change after B.C. nurse dies by suicide after attacks on the job

Product reduces TPH levels to non-hazardous status

Hospital Mergers Fail to Deliver Better Care or Lower Costs, Study Finds todayheadline

Police ID man who died after Corso Italia fight

Harris tells supporters ‘never give up’ and urges peaceful transfer of power

Des Moines Man Accused Of Shooting Ex-Girlfriend’s Mother

Trump ‘looks forward’ to White House meeting with Biden

Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

Goldman Sachs: AI, not tariffs, are best bet to boosting U.S. manufacturing productivity todayheadline

Freedom Holding Corp.: S&P Global Ratings Upgrades Outlook on Key Operating Subsidiaries to "Positive" on Strengthened Risk Management and Compliance todayheadline

Struggling to Stick to a Routine? Here’s How AI Can Help todayheadline

A Physicist Explains The Explosive Birth of The Universe’s Building Blocks : ScienceAlert todayheadline

Recent News

Goldman Sachs: AI, not tariffs, are best bet to boosting U.S. manufacturing productivity todayheadline

Freedom Holding Corp.: S&P Global Ratings Upgrades Outlook on Key Operating Subsidiaries to "Positive" on Strengthened Risk Management and Compliance todayheadline

Struggling to Stick to a Routine? Here’s How AI Can Help todayheadline

A Physicist Explains The Explosive Birth of The Universe’s Building Blocks : ScienceAlert todayheadline

Browse by Category

Recent News

Goldman Sachs: AI, not tariffs, are best bet to boosting U.S. manufacturing productivity todayheadline

Freedom Holding Corp.: S&P Global Ratings Upgrades Outlook on Key Operating Subsidiaries to "Positive" on Strengthened Risk Management and Compliance todayheadline